These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 15296848
1. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Exp Neurol; 2004 Sep; 189(1):182-8. PubMed ID: 15296848 [Abstract] [Full Text] [Related]
2. Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease. Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. J Neurol Sci; 2006 Oct 25; 248(1-2):48-52. PubMed ID: 16780890 [Abstract] [Full Text] [Related]
3. Differential effects of adenosine antagonists in two models of parkinsonian tremor. Trevitt J, Kawa K, Jalali A, Larsen C. Pharmacol Biochem Behav; 2009 Nov 25; 94(1):24-9. PubMed ID: 19602422 [Abstract] [Full Text] [Related]
4. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. Betz AJ, Vontell R, Valenta J, Worden L, Sink KS, Font L, Correa M, Sager TN, Salamone JD. Neuroscience; 2009 Sep 29; 163(1):97-108. PubMed ID: 19467297 [Abstract] [Full Text] [Related]
9. Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists. Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Exp Neurol; 2006 Nov 29; 202(1):255-7. PubMed ID: 16808917 [Abstract] [Full Text] [Related]
10. Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements. Johnson JA, Montgomery AP, Starr ER, Ludwig J, Trevitt J. Eur J Pharmacol; 2018 Aug 15; 833():364-369. PubMed ID: 29883670 [Abstract] [Full Text] [Related]
11. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect. Miwa H, Kubo T, Suzuki A, Kondo T. Parkinsonism Relat Disord; 2009 Jan 15; 15(1):30-5. PubMed ID: 18693129 [Abstract] [Full Text] [Related]
12. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Pinna A, Tronci E, Schintu N, Simola N, Volpini R, Pontis S, Cristalli G, Morelli M. Neuropharmacology; 2010 Mar 15; 58(3):613-23. PubMed ID: 19951715 [Abstract] [Full Text] [Related]
13. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD. Pharmacol Biochem Behav; 2011 Sep 15; 99(3):414-22. PubMed ID: 21640750 [Abstract] [Full Text] [Related]
17. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats. Wardas J, Konieczny J, Lorenc-Koci E. Synapse; 2001 Aug 15; 41(2):160-71. PubMed ID: 11400182 [Abstract] [Full Text] [Related]
18. Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration. Minghetti L, Greco A, Potenza RL, Pezzola A, Blum D, Bantubungi K, Popoli P. J Neuropathol Exp Neurol; 2007 May 15; 66(5):363-71. PubMed ID: 17483693 [Abstract] [Full Text] [Related]
20. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats. Ishiwari K, Betz A, Weber S, Felsted J, Salamone JD. Pharmacol Biochem Behav; 2005 Feb 15; 80(2):351-62. PubMed ID: 15680188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]